Navigation Links
iJET to Lead Discussion on Supplier Resiliency at Continuity Insights Management Conference
Date:4/5/2011

ANNAPOLIS, Md., April 5, 2011 /PRNewswire/ -- Steve Hoffman, Chief Executive Officer of iJET Intelligent Risk Systems, a leading provider of global intelligence and business resiliency services, will present information on the importance of supplier resiliency at the Continuity Insights 2011 Management Conference. Introducing a case study from a leading medical technology company – where defects and delays could be life-threatening to patients – Hoffman will assert the need to assess critical suppliers across a range of risk categories and monitor ongoing threats to those suppliers.  The session will offer attendees practical insight and best practices for leveraging intelligence and technology to strengthen critical supplier resiliency.   SESSION:A9 - "Continuity Pulse Check: Supplier Resiliency"WHEN:Tuesday, April 12 at 3:30 p.m. EDTPRESENTER:Steve Hoffman, CEO at iJET Intelligent Risk SystemsCONFERENCE:Continuity Insights 2011 Management Conference Hyatt Regency, AtlantaThe Continuity Insights 2011 Management Conference is a three-day event that brings together continuity and security experts from across the globe to discuss and share continuity planning and strategies to help executives embrace and apply business continuity practices within their organizations. This year's conference will be held from April 11-13 in Atlanta.

About iJET Intelligent Risk SystemsiJET Intelligent Risk Systems (iJET) is an intelligence-driven provider of business resiliency and risk management solutions to nearly 500 multinational corporations and governments – helping them survive and thrive amidst global threats to their people, facilities and supply chain assets.

iJET's services, team of world-class intelligence analysts and patented Worldcue® Global Control Center technology solutions equip decision-makers and organizations with real-time information to anticipate, respond to and emerge from business disruptions with a competitive edge. iJET's Worldcue solutions provide decision makers with timely, actionable intelligence on potential disruptions and emerging threats to employees, operating assets and suppliers.

For more information, please visit: www.ijet.com/resilient.

iJET, Travel Intelligence and Worldcue are registered trademarks of iJET Intelligent Risk Systems, Inc.  All rights reserved.

www.ijet.com


'/>"/>

SOURCE iJET Intelligent Risk Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
2. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
3. ISIS PHARMACEUTICALS TO DISCUSS PRODUCTIVE REGULATORY DISCUSSIONS REGARDING THE MIPOMERSEN NDA FILING
4. VIDEO from International Osteoporosis Foundation available on thenewsmarket.com: IOF Focuses on WHO Fracture Risk Assessment Tool for International Discussions
5. MPO Symposium Panel Discussion to Address Open-Book Pricing and Its Effect on Long-Term Performance
6. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results
7. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
8. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
9. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
10. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results
11. Orexigen(R) Therapeutics Schedules May 10, 2010 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology:
(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
Breaking Medicine News(10 mins):